Plexus (PLXS) Stock Forecast & Price Target

Plexus is attractive fundamentally because demand is broadening across healthcare, industrial, semiconductor capital equipment, and aerospace/defense, with revenue tracking toward $1B in 2H and growth of 28% YoY through F2H, while design-win momentum and a ~$500M AI data center pipeline support durability. It is also translating scale into better economics: operating margin ended FY25 at 5.9% and exited last quarter at 6.3%, above the 6% target, aided by fixed-cost leverage, automation, and AI-enabled efficiency gains that have already avoided about $20M of capex. Free cash flow should recover as working capital normalizes, with cash cycle days at 62 and capacity additions of about $500M coming online within a modular framework that keeps capex at 2-3% of revenue.

Plexus is vulnerable to a weaker demand backdrop, with risks tied to global supply chain instability, tariff-driven economic slowdown, and possible softness in its major end markets, especially if commercial aerospace recovery stalls or semicap demand normalizes after current strength. The company also faces customer concentration and execution risk, as losing a key customer or experiencing pushouts could slow funnel conversion and reduce wins replenishment, while manufacturing disruptions would further pressure operations. Profitability appears constrained by increased compensation, technology, and program-ramp investments that could keep operating margin below the 6% target, and the CFO transition adds near-term uncertainty amid weaker earnings visibility.